HEADER STRUCTURAL PROTEIN 02-JUL-20 6XND TITLE AVIDIN-BIOTIN-PHENOL CAVEAT 6XND NAG A 201 HAS WRONG CHIRALITY AT ATOM C1 V8M B 202 HAS WRONG CAVEAT 2 6XND CHIRALITY AT ATOM C13 V8M B 202 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 6XND C18 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AVIDIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: AVD; SOURCE 6 EXPRESSION_SYSTEM: GALLUS GALLUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9031 KEYWDS THE COMPLEX OF AVIDIN AND BIOTIN-PHENOL, STRUCTURAL GENOMICS, PSI-2, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.AHMADVAND,C.KANG REVDAT 2 18-OCT-23 6XND 1 REMARK REVDAT 1 03-MAR-21 6XND 0 JRNL AUTH A.J.BURT,P.AHMADVAND,L.K.OPP,A.T.RYAN,C.KANG,R.J.MANCINI JRNL TITL A LIGAND-DIRECTED NITROPHENOL CARBONATE FOR TRANSIENT IN JRNL TITL 2 SITU BIOCONJUGATION AND DRUG DELIVERY JRNL REF CHEMMEDCHEM V. 15 2004 2020 JRNL REFN ESSN 1860-7187 JRNL DOI 10.1002/CMDC.202000655 REMARK 2 REMARK 2 RESOLUTION. 1.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.16_3549 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.84 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 71463 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.780 REMARK 3 FREE R VALUE TEST SET COUNT : 1987 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 4.6460 - 3.8073 1.00 5050 146 0.1880 0.2232 REMARK 3 2 3.8073 - 3.0222 1.00 5010 141 0.2234 0.2599 REMARK 3 3 3.0222 - 2.6402 1.00 4954 144 0.2442 0.2681 REMARK 3 4 2.6402 - 2.3988 1.00 4961 144 0.2514 0.2959 REMARK 3 5 2.3988 - 2.2269 1.00 4983 133 0.2509 0.2813 REMARK 3 6 2.2269 - 2.0956 1.00 4966 142 0.2477 0.2898 REMARK 3 7 2.0956 - 1.9907 1.00 4962 151 0.2432 0.2809 REMARK 3 8 1.9907 - 1.9040 1.00 4921 142 0.2468 0.3361 REMARK 3 9 1.9040 - 1.8307 1.00 4977 131 0.2629 0.3049 REMARK 3 10 1.8307 - 1.7675 1.00 4950 143 0.2794 0.3088 REMARK 3 11 1.7675 - 1.7123 1.00 4951 142 0.2874 0.3587 REMARK 3 12 1.7123 - 1.6633 1.00 4937 133 0.3045 0.3097 REMARK 3 13 1.6633 - 1.6195 1.00 4925 151 0.3274 0.3620 REMARK 3 14 1.6195 - 1.5800 0.99 4929 144 0.3494 0.4008 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.830 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 4032 REMARK 3 ANGLE : 1.525 5464 REMARK 3 CHIRALITY : 0.443 632 REMARK 3 PLANARITY : 0.007 676 REMARK 3 DIHEDRAL : 9.981 2316 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6XND COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1000250286. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-20 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 7.0-7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 71463 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.580 REMARK 200 RESOLUTION RANGE LOW (A) : 44.843 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2AVI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, PH 7.0, AND 25% (W/V) PEG REMARK 280 1500, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.62700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ARG A 2 REMARK 465 ARG A 124 REMARK 465 THR A 125 REMARK 465 GLN A 126 REMARK 465 LYS A 127 REMARK 465 GLU A 128 REMARK 465 ALA B 1 REMARK 465 ARG B 2 REMARK 465 ARG B 124 REMARK 465 THR B 125 REMARK 465 GLN B 126 REMARK 465 LYS B 127 REMARK 465 GLU B 128 REMARK 465 ALA C 1 REMARK 465 ARG C 2 REMARK 465 ARG C 124 REMARK 465 THR C 125 REMARK 465 GLN C 126 REMARK 465 LYS C 127 REMARK 465 GLU C 128 REMARK 465 ALA D 1 REMARK 465 ARG D 2 REMARK 465 ARG D 124 REMARK 465 THR D 125 REMARK 465 GLN D 126 REMARK 465 LYS D 127 REMARK 465 GLU D 128 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU D 91 HH12 ARG D 122 1.42 REMARK 500 OE1 GLU B 91 HH12 ARG B 122 1.45 REMARK 500 HG SER A 101 O01 V8M A 202 1.54 REMARK 500 OG SER A 101 O01 V8M A 202 1.77 REMARK 500 OG SER D 101 O01 V8M D 202 1.81 REMARK 500 OD1 ASN B 118 O17 V8M B 202 1.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 49 CA - CB - CG ANGL. DEV. = 21.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 54 62.54 -100.10 REMARK 500 THR A 55 -54.67 47.66 REMARK 500 ILE A 56 -96.30 -52.95 REMARK 500 LYS A 58 37.73 38.94 REMARK 500 ASP A 86 156.91 -43.21 REMARK 500 LYS B 58 57.53 25.67 REMARK 500 LYS C 58 45.91 38.83 REMARK 500 ASP C 86 169.83 -49.21 REMARK 500 ASN C 88 9.74 -65.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 54 THR A 55 116.58 REMARK 500 THR A 55 ILE A 56 -141.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG B 201 REMARK 610 NAG C 201 REMARK 610 NAG D 201 REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 NAG A 201 REMARK 615 NAG B 201 REMARK 615 NAG C 201 REMARK 615 NAG D 201 DBREF 6XND A 1 128 UNP P02701 AVID_CHICK 25 152 DBREF 6XND B 1 128 UNP P02701 AVID_CHICK 25 152 DBREF 6XND C 1 128 UNP P02701 AVID_CHICK 25 152 DBREF 6XND D 1 128 UNP P02701 AVID_CHICK 25 152 SEQADV 6XND THR A 34 UNP P02701 ILE 58 VARIANT SEQADV 6XND GLU A 53 UNP P02701 GLN 77 CONFLICT SEQADV 6XND THR B 34 UNP P02701 ILE 58 VARIANT SEQADV 6XND GLU B 53 UNP P02701 GLN 77 CONFLICT SEQADV 6XND THR C 34 UNP P02701 ILE 58 VARIANT SEQADV 6XND GLU C 53 UNP P02701 GLN 77 CONFLICT SEQADV 6XND THR D 34 UNP P02701 ILE 58 VARIANT SEQADV 6XND GLU D 53 UNP P02701 GLN 77 CONFLICT SEQRES 1 A 128 ALA ARG LYS CYS SER LEU THR GLY LYS TRP THR ASN ASP SEQRES 2 A 128 LEU GLY SER ASN MET THR ILE GLY ALA VAL ASN SER ARG SEQRES 3 A 128 GLY GLU PHE THR GLY THR TYR THR THR ALA VAL THR ALA SEQRES 4 A 128 THR SER ASN GLU ILE LYS GLU SER PRO LEU HIS GLY THR SEQRES 5 A 128 GLU ASN THR ILE ASN LYS ARG THR GLN PRO THR PHE GLY SEQRES 6 A 128 PHE THR VAL ASN TRP LYS PHE SER GLU SER THR THR VAL SEQRES 7 A 128 PHE THR GLY GLN CYS PHE ILE ASP ARG ASN GLY LYS GLU SEQRES 8 A 128 VAL LEU LYS THR MET TRP LEU LEU ARG SER SER VAL ASN SEQRES 9 A 128 ASP ILE GLY ASP ASP TRP LYS ALA THR ARG VAL GLY ILE SEQRES 10 A 128 ASN ILE PHE THR ARG LEU ARG THR GLN LYS GLU SEQRES 1 B 128 ALA ARG LYS CYS SER LEU THR GLY LYS TRP THR ASN ASP SEQRES 2 B 128 LEU GLY SER ASN MET THR ILE GLY ALA VAL ASN SER ARG SEQRES 3 B 128 GLY GLU PHE THR GLY THR TYR THR THR ALA VAL THR ALA SEQRES 4 B 128 THR SER ASN GLU ILE LYS GLU SER PRO LEU HIS GLY THR SEQRES 5 B 128 GLU ASN THR ILE ASN LYS ARG THR GLN PRO THR PHE GLY SEQRES 6 B 128 PHE THR VAL ASN TRP LYS PHE SER GLU SER THR THR VAL SEQRES 7 B 128 PHE THR GLY GLN CYS PHE ILE ASP ARG ASN GLY LYS GLU SEQRES 8 B 128 VAL LEU LYS THR MET TRP LEU LEU ARG SER SER VAL ASN SEQRES 9 B 128 ASP ILE GLY ASP ASP TRP LYS ALA THR ARG VAL GLY ILE SEQRES 10 B 128 ASN ILE PHE THR ARG LEU ARG THR GLN LYS GLU SEQRES 1 C 128 ALA ARG LYS CYS SER LEU THR GLY LYS TRP THR ASN ASP SEQRES 2 C 128 LEU GLY SER ASN MET THR ILE GLY ALA VAL ASN SER ARG SEQRES 3 C 128 GLY GLU PHE THR GLY THR TYR THR THR ALA VAL THR ALA SEQRES 4 C 128 THR SER ASN GLU ILE LYS GLU SER PRO LEU HIS GLY THR SEQRES 5 C 128 GLU ASN THR ILE ASN LYS ARG THR GLN PRO THR PHE GLY SEQRES 6 C 128 PHE THR VAL ASN TRP LYS PHE SER GLU SER THR THR VAL SEQRES 7 C 128 PHE THR GLY GLN CYS PHE ILE ASP ARG ASN GLY LYS GLU SEQRES 8 C 128 VAL LEU LYS THR MET TRP LEU LEU ARG SER SER VAL ASN SEQRES 9 C 128 ASP ILE GLY ASP ASP TRP LYS ALA THR ARG VAL GLY ILE SEQRES 10 C 128 ASN ILE PHE THR ARG LEU ARG THR GLN LYS GLU SEQRES 1 D 128 ALA ARG LYS CYS SER LEU THR GLY LYS TRP THR ASN ASP SEQRES 2 D 128 LEU GLY SER ASN MET THR ILE GLY ALA VAL ASN SER ARG SEQRES 3 D 128 GLY GLU PHE THR GLY THR TYR THR THR ALA VAL THR ALA SEQRES 4 D 128 THR SER ASN GLU ILE LYS GLU SER PRO LEU HIS GLY THR SEQRES 5 D 128 GLU ASN THR ILE ASN LYS ARG THR GLN PRO THR PHE GLY SEQRES 6 D 128 PHE THR VAL ASN TRP LYS PHE SER GLU SER THR THR VAL SEQRES 7 D 128 PHE THR GLY GLN CYS PHE ILE ASP ARG ASN GLY LYS GLU SEQRES 8 D 128 VAL LEU LYS THR MET TRP LEU LEU ARG SER SER VAL ASN SEQRES 9 D 128 ASP ILE GLY ASP ASP TRP LYS ALA THR ARG VAL GLY ILE SEQRES 10 D 128 ASN ILE PHE THR ARG LEU ARG THR GLN LYS GLU HET NAG A 201 28 HET V8M A 202 52 HET NAG B 201 28 HET V8M B 202 52 HET NAG C 201 28 HET V8M C 202 52 HET NAG D 201 28 HET V8M D 202 52 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM V8M N-[2-(2-HYDROXY-5-NITROPHENYL)ETHYL]-5-[(3AS,4S,6AS)-2- HETNAM 2 V8M OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 4(C8 H15 N O6) FORMUL 6 V8M 4(C18 H24 N4 O5 S) HELIX 1 AA1 ASP A 105 LYS A 111 5 7 HELIX 2 AA2 ASP B 105 LYS B 111 5 7 HELIX 3 AA3 ASP C 105 LYS C 111 5 7 HELIX 4 AA4 ASP D 105 LYS D 111 5 7 SHEET 1 AA1 9 GLY A 8 ASN A 12 0 SHEET 2 AA1 9 ASN A 17 ILE A 20 -1 O ILE A 20 N GLY A 8 SHEET 3 AA1 9 GLU A 28 THR A 34 -1 O THR A 34 N ASN A 17 SHEET 4 AA1 9 SER A 47 ASN A 54 -1 O SER A 47 N TYR A 33 SHEET 5 AA1 9 THR A 63 ASN A 69 -1 O THR A 63 N ASN A 54 SHEET 6 AA1 9 THR A 76 ILE A 85 -1 O THR A 77 N VAL A 68 SHEET 7 AA1 9 GLU A 91 ARG A 100 -1 O ARG A 100 N THR A 76 SHEET 8 AA1 9 THR A 113 ARG A 122 -1 O ARG A 114 N LEU A 99 SHEET 9 AA1 9 GLY A 8 ASN A 12 -1 N THR A 11 O THR A 121 SHEET 1 AA2 9 GLY B 8 ASN B 12 0 SHEET 2 AA2 9 ASN B 17 ILE B 20 -1 O ILE B 20 N GLY B 8 SHEET 3 AA2 9 GLU B 28 THR B 34 -1 O THR B 34 N ASN B 17 SHEET 4 AA2 9 SER B 47 GLU B 53 -1 O SER B 47 N TYR B 33 SHEET 5 AA2 9 THR B 63 ASN B 69 -1 O THR B 67 N HIS B 50 SHEET 6 AA2 9 THR B 76 ILE B 85 -1 O THR B 77 N VAL B 68 SHEET 7 AA2 9 GLU B 91 ARG B 100 -1 O ARG B 100 N THR B 76 SHEET 8 AA2 9 THR B 113 ARG B 122 -1 O GLY B 116 N TRP B 97 SHEET 9 AA2 9 GLY B 8 ASN B 12 -1 N THR B 11 O THR B 121 SHEET 1 AA3 9 GLY C 8 ASN C 12 0 SHEET 2 AA3 9 ASN C 17 ILE C 20 -1 O MET C 18 N TRP C 10 SHEET 3 AA3 9 GLU C 28 THR C 34 -1 O THR C 34 N ASN C 17 SHEET 4 AA3 9 SER C 47 GLU C 53 -1 O SER C 47 N TYR C 33 SHEET 5 AA3 9 THR C 63 ASN C 69 -1 O THR C 67 N HIS C 50 SHEET 6 AA3 9 THR C 76 ILE C 85 -1 O THR C 77 N VAL C 68 SHEET 7 AA3 9 GLU C 91 ARG C 100 -1 O ARG C 100 N THR C 76 SHEET 8 AA3 9 THR C 113 ARG C 122 -1 O GLY C 116 N TRP C 97 SHEET 9 AA3 9 GLY C 8 ASN C 12 -1 N THR C 11 O THR C 121 SHEET 1 AA4 9 GLY D 8 ASN D 12 0 SHEET 2 AA4 9 ASN D 17 ILE D 20 -1 O MET D 18 N TRP D 10 SHEET 3 AA4 9 GLU D 28 THR D 34 -1 O THR D 34 N ASN D 17 SHEET 4 AA4 9 SER D 47 GLU D 53 -1 O SER D 47 N TYR D 33 SHEET 5 AA4 9 THR D 63 ASN D 69 -1 O THR D 67 N HIS D 50 SHEET 6 AA4 9 THR D 76 ILE D 85 -1 O THR D 77 N VAL D 68 SHEET 7 AA4 9 GLU D 91 ARG D 100 -1 O ARG D 100 N THR D 76 SHEET 8 AA4 9 THR D 113 ARG D 122 -1 O ARG D 114 N LEU D 99 SHEET 9 AA4 9 GLY D 8 ASN D 12 -1 N THR D 11 O THR D 121 SSBOND 1 CYS A 4 CYS A 83 1555 1555 2.00 SSBOND 2 CYS B 4 CYS B 83 1555 1555 2.02 SSBOND 3 CYS C 4 CYS C 83 1555 1555 2.03 SSBOND 4 CYS D 4 CYS D 83 1555 1555 2.01 LINK ND2 ASN A 17 C1 NAG A 201 1555 1555 1.43 CRYST1 46.526 79.254 74.683 90.00 105.46 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021493 0.000000 0.005943 0.00000 SCALE2 0.000000 0.012618 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013892 0.00000